Jump Financial LLC Boosts Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• Jump Financial LLC increased its stake in Intuitive Surgical by 21.9%, acquiring an additional 9,455 shares in the first quarter, bringing their total to 52,564 shares valued at approximately $26 million.
• Several institutional investors, including Castleark Management LLC and Arlington Trust Co LLC, have also boosted their holdings in Intuitive Surgical, demonstrating strong institutional interest in the company.
• Intuitive Surgical's stock has been rated a "Moderate Buy" by analysts, with an average price target of $595.95, indicating positive sentiment among market experts despite recent insider selling activity.

Jump Financial LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 21.9% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 52,564 shares of the medical equipment provider's stock after purchasing an additional 9,455 shares during the period. Jump Financial LLC's holdings in Intuitive Surgical were worth $26,033,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. Castleark Management LLC raised its holdings in shares of Intuitive Surgical by 3.4% in the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after purchasing an additional 2,990 shares in the last quarter. Arlington Trust Co LLC boosted its holdings in Intuitive Surgical by 34.5% during the first quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock worth $369,000 after buying an additional 191 shares in the last quarter. Aveo Capital Partners LLC boosted its holdings in Intuitive Surgical by 37.4% during the first quarter. Aveo Capital Partners LLC now owns 727 shares of the medical equipment provider's stock worth $390,000 after buying an additional 198 shares in the last quarter. Aaron Wealth Advisors LLC raised its position in Intuitive Surgical by 3.2% during the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock worth $1,243,000 after acquiring an additional 78 shares during the last quarter. Finally, Longbow Finance SA raised its position in shares of Intuitive Surgical by 132.0% in the first quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider's stock valued at $9,756,000 after buying an additional 11,209 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares of the company's stock, valued at $173,845.44. This represents a 92.73% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Mark Brosius sold 216 shares of the stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president directly owned 907 shares in the company, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,839 shares of company stock worth $7,896,972. Corporate insiders own 0.70% of the company's stock.

Analyst Ratings Changes

ISRG has been the subject of several research analyst reports. Truist Financial upped their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. BTIG Research upped their price target on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a report on Wednesday, July 23rd. Citigroup reiterated a "buy" rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Finally, Zacks Research lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Wednesday. Thirteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $595.95.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $476.16 on Friday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The stock has a market cap of $170.69 billion, a PE ratio of 66.41, a PEG ratio of 4.92 and a beta of 1.59. The business has a fifty day moving average of $504.42 and a two-hundred day moving average of $522.06.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same period last year, the company earned $1.78 earnings per share. The company's revenue was up 21.4% on a year-over-year basis. Analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.